Industry News
Improved survival in women with recurrent ovarian cancer prescribed biological therapy with cediranib
Oct 02, 2013
Women with ovarian cancer that has recurred after chemotherapy have survived for longer after treatment with a biological therapy called cediranib, according to new results presented at the 2013 European Cancer Congress (ECC2013) [1]... Read More
Aspirin may act on two different pathways to improve survival in colon cancer
Oct 02, 2013
Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) [1] heard. Although previous research has shown that taking low dose aspirin after being diagnosed with colon cancer improves patient outcome, the reasons why this happens remain unknown... Read More
Abnormal DNA methylation precedes cancer initiation: non-invasive tests a future possibility
Oct 02, 2013
Unique DNA markings on certain genes may "predict" the risk of developing head and neck cancer, according to new research led by Queen Mary University of London. The findings, published in the journal Cancer, raise the potential for the development of non-invasive tests which could pick up these tell-tale signs of early cancer initiation... Read More
Cancer diagnosis and treatment may improve with liquid biopsy
Oct 02, 2013
A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood - and it can support the cells' growth for further analysis. The device, believed to be the first to pair these functions, uses the advanced electronics material graphene oxide... Read More
Cancer therapies likely to improve with new insights into DNA repair process
Oct 02, 2013
By detailing a process required for repairing DNA breakage, scientists at the Duke Cancer Institute have gained a better understanding of how cells deal with the barrage of damage that can contribute to cancer and other diseases. The insights, reported online the week of Sept... Read More
Urgent need to tackle disparities in cancer care worldwide the focus of new report
Oct 02, 2013
A proposal for a new financing model to tackle the major disparities that exist in the prevention, diagnosis, treatment and outcome of cancer in countries worldwide has been presented at the 2013 European Cancer Congress (ECCO 2013)... Read More
First pre-surgery breast cancer drug approved by FDA
Oct 02, 2013
The US Food and Drug Administration (FDA) has approved the first drug to be used in early stage breast cancer treatment. Perjeta (pertuzumab) will be used as part of a complete treatment regimen for patients before surgery (neoadjuvant setting)... Read More
Compound developed that may treat erectile dysfunction priapism
Oct 02, 2013
It's not the little blue pill famous for helping men get big results, but for those who need it, the outcome might be even more significant. A new research report published online in The FASEB Journal, offers hope to men who experience priapism. This condition, which is often seen in men with sickle cell disease, causes erections lasting so long that they cause permanent damage to the penis... Read More
Dealing with side-effects of hormone therapy for prostate cancer
Oct 02, 2013
Flushed face, sweating, a sudden rush of heat. The hot flash, the bane of menopausal women, also can affect men who are undergoing hormone therapy for prostate cancer. But unlike in women, neither soy protein nor a common antidepressant provides relief for men, according to researchers at Wake Forest Baptist Medical Center... Read More
Improved survival in women with recurrent ovarian cancer prescribed biological therapy with cediranib
Oct 02, 2013
Women with ovarian cancer that has recurred after chemotherapy have survived for longer after treatment with a biological therapy called cediranib, according to new results presented at the 2013 European Cancer Congress (ECC2013) [1]... Read More
Previous Page Next Page